论文部分内容阅读
我们于1977年至1984年采用奎尼丁加异搏停联合用药,对39例持续房颤病人进行复律治疗,现报道如下.一般资料慢性房颤患者39例,其中男24例,女15例.年龄21～62岁,房颤持续时间0.5～3年,心胸比例大于50%占27例,伴心衰者3例.房颤原发病因:风心33例,冠心3例,其它3例。给药方法:首次奎尼丁0.2g,第二次(2小时后)再给0.4g,第三次给药视病人的心率、血压及消化道反应情况、以及心电监护的改变,在2小时或4小时后给奎尼丁0.2或0.4g,如仍不能复律的病例于4小时后第四次再给0.2g,若仍不能转复,则在6小时后,第五次再给0.2g,仍无效者,不再转复.每次给奎尼丁同时给异搏停20～40mg。在用药过程中,如出现血压偏低或心动过缓,加用异丙
We used quinidine and verapamil combination therapy from 1977 to 1984 in 39 patients with persistent atrial fibrillation cardioversion, are reported as follows.General information 39 patients with chronic atrial fibrillation, including 24 males and 15 females Cases aged 21 to 62 years, duration of atrial fibrillation 0.5 to 3 years, cardiothoracic ratio greater than 50% of 27 cases with heart failure in 3. Primary causes of atrial fibrillation: 33 cases of coronary heart disease, coronary heart in 3 cases, other 3 cases. Method of administration: first quinidine 0.2g, the second (after 2 hours) to give 0.4g, the third dose depending on the patient’s heart rate, blood pressure and gastrointestinal reactions, and ECG changes in care 2 Hours or 4 hours to give quinidine 0.2 or 0.4g, such as still can not cardioversion in 4 hours after the fourth give 0.2g, if still can not be transferred, then after 6 hours, the fifth to give 0.2g, still ineffective, no longer transferred to each time given Quinidine to different stroke stop 20 ~ 40mg. In the course of medication, such as low blood pressure or bradycardia, plus isopropyl